1P0I - JenaLib

Asymmetric Unit (18, 18)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	ASN A:241 , ASN A:245 , NAG A:531 , FUC A:532	BINDING SITE FOR RESIDUE NAG A 530
02	AC2	SOFTWARE	NAG A:530	BINDING SITE FOR RESIDUE NAG A 531
03	AC3	SOFTWARE	ASN A:245 , LEU A:249 , PHE A:278 , NAG A:530 , HOH A:812	BINDING SITE FOR RESIDUE FUC A 532
04	AC4	SOFTWARE	SER A:338 , ASN A:341 , ASN A:342 , NAG A:534 , FUC A:535 , HOH A:1095	BINDING SITE FOR RESIDUE NAG A 533
05	AC5	SOFTWARE	GLY A:336 , NAG A:533	BINDING SITE FOR RESIDUE NAG A 534
06	AC6	SOFTWARE	NAG A:533 , HOH A:1039 , HOH A:1165	BINDING SITE FOR RESIDUE FUC A 535
07	AC7	SOFTWARE	LYS A:105 , ASN A:106 , ASN A:188 , LYS A:190 , HOH A:754 , HOH A:838 , HOH A:1030 , HOH A:1158	BINDING SITE FOR RESIDUE NAG A 536
08	AC8	SOFTWARE	ARG A:14 , ASN A:57 , HOH A:1155	BINDING SITE FOR RESIDUE NAG A 537
09	AC9	SOFTWARE	ARG A:465 , LYS A:469 , ASN A:485	BINDING SITE FOR RESIDUE NAG A 538
10	BC1	SOFTWARE	GLN A:316 , GLY A:413 , ASN A:414 , ASN A:415	BINDING SITE FOR RESIDUE SO4 A 601
11	BC2	SOFTWARE	PHE A:521 , PHE A:525 , LYS A:528 , HOH A:762 , HOH A:1140	BINDING SITE FOR RESIDUE SO4 A 602
12	BC3	SOFTWARE	HOH A:967	BINDING SITE FOR RESIDUE CL A 701
13	BC4	SOFTWARE	THR A:488 , THR A:508 , HOH A:1049	BINDING SITE FOR RESIDUE CL A 702
14	BC5	SOFTWARE	GLY A:116 , GLY A:117 , SER A:198 , ALA A:199 , HIS A:438 , GOL A:605	BINDING SITE FOR RESIDUE BUA A 606
15	BC6	SOFTWARE	LYS A:323 , TYR A:420 , ARG A:509 , LEU A:514 , ARG A:515 , HOH A:975 , HOH A:983	BINDING SITE FOR RESIDUE MES A 607
16	BC7	SOFTWARE	LEU A:18 , LEU A:29 , TYR A:61 , TRP A:98 , ASP A:129 , LYS A:131	BINDING SITE FOR RESIDUE GOL A 603
17	BC8	SOFTWARE	TRP A:231 , THR A:234 , GLU A:238 , ARG A:242 , VAL A:288 , HOH A:937 , HOH A:999 , HOH A:1128	BINDING SITE FOR RESIDUE GOL A 604
18	BC9	SOFTWARE	TRP A:82 , GLY A:116 , GLU A:197 , BUA A:606 , HOH A:786 , HOH A:875	BINDING SITE FOR RESIDUE GOL A 605

SS Bonds (3, 3)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (42, 42)

Asymmetric Unit (42, 42)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_072094	K	40	R	CHLE_HUMAN	Polymorphism	116047990	A	K	12	R
02	UniProt	VAR_040012	T	52	M	CHLE_HUMAN	Disease (BChE deficiency)	56309853	A	T	24	M
03	UniProt	VAR_040013	F	56	I	CHLE_HUMAN	Disease (BChE deficiency)	531738678	A	F	28	I
04	UniProt	VAR_040014	Y	61	C	CHLE_HUMAN	Disease (BChE deficiency)	116097205	A	Y	33	C
05	UniProt	VAR_072730	A	62	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	34	V
06	UniProt	VAR_040015	P	65	S	CHLE_HUMAN	Disease (BChE deficiency)	148170012	A	P	37	S
07	UniProt	VAR_002360	D	98	G	CHLE_HUMAN	Disease (BChE deficiency)	1799807	A	D	70	G
08	UniProt	VAR_040016	D	98	H	CHLE_HUMAN	Disease (BChE deficiency)	---	A	D	70	H
09	UniProt	VAR_072095	G	103	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A	G	75	R
10	UniProt	VAR_072096	E	118	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A	E	90	D
11	UniProt	VAR_040017	N	124	Y	CHLE_HUMAN	Disease (BChE deficiency)	---	A	N	96	Y
12	UniProt	VAR_072097	I	127	M	CHLE_HUMAN	Polymorphism	755600722	A	I	99	M
13	UniProt	VAR_040018	P	128	S	CHLE_HUMAN	Disease (BChE deficiency)	3732880	A	P	100	S
14	UniProt	VAR_040019	G	143	D	CHLE_HUMAN	Disease (BChE deficiency)	201820739	A	G	115	D
15	UniProt	VAR_040020	L	153	F	CHLE_HUMAN	Disease (BChE deficiency)	747598704	A	L	125	F
16	UniProt	VAR_040021	Y	156	C	CHLE_HUMAN	Disease (BChE deficiency)	121918558	A	Y	128	C
17	UniProt	VAR_040022	V	170	M	CHLE_HUMAN	Disease (BChE deficiency)	527843566	A	V	142	M
18	UniProt	VAR_040023	D	198	E	CHLE_HUMAN	Disease (BChE deficiency)	781368801	A	D	170	E
19	UniProt	VAR_040024	S	226	G	CHLE_HUMAN	Disease (BChE deficiency)	370077923	A	S	198	G
20	UniProt	VAR_040025	A	227	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	199	V
21	UniProt	VAR_040026	A	229	T	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	201	T
22	UniProt	VAR_072098	V	232	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A	V	204	D
23	UniProt	VAR_040027	T	271	M	CHLE_HUMAN	Disease (BChE deficiency)	28933389	A	T	243	M
24	UniProt	VAR_040028	T	278	P	CHLE_HUMAN	Disease (BChE deficiency)	---	A	T	250	P
25	UniProt	VAR_040029	E	283	D	CHLE_HUMAN	Polymorphism	16849700	A	E	255	D
26	UniProt	VAR_040030	K	295	R	CHLE_HUMAN	Disease (BChE deficiency)	115624085	A	K	267	R
27	UniProt	VAR_072099	V	322	M	CHLE_HUMAN	Polymorphism	754644618	A	V	294	M
28	UniProt	VAR_040031	L	335	P	CHLE_HUMAN	Disease (BChE deficiency)	104893684	A	L	307	P
29	UniProt	VAR_040032	A	356	D	CHLE_HUMAN	Disease (BChE deficiency)	770337031	A	A	328	D
30	UniProt	VAR_002362	L	358	I	CHLE_HUMAN	Disease (BChE deficiency)	121918557	A	L	330	I
31	UniProt	VAR_072100	G	361	C	CHLE_HUMAN	Disease (BChE deficiency)	---	A	G	333	C
32	UniProt	VAR_040033	G	393	R	CHLE_HUMAN	Disease (BChE deficiency)	115129687	A	G	365	R
33	UniProt	VAR_040034	R	414	C	CHLE_HUMAN	Disease (BChE deficiency)	745364489	A	R	386	C
34	UniProt	VAR_040035	G	418	V	CHLE_HUMAN	Disease (BChE deficiency)	28933390	A	G	390	V
35	UniProt	VAR_040036	F	446	S	CHLE_HUMAN	Disease (BChE deficiency)	---	A	F	418	S
36	UniProt	VAR_040037	E	488	K	CHLE_HUMAN	Disease (BChE deficiency)	200998515	A	E	460	K
37	UniProt	VAR_072101	R	498	W	CHLE_HUMAN	Polymorphism	115017300	A	R	470	W
38	UniProt	VAR_040038	W	499	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A	W	471	R
39	UniProt	VAR_040039	F	502	L	CHLE_HUMAN	Disease (BChE deficiency)	769316835	A	F	474	L
40	UniProt	VAR_040040	E	525	V	CHLE_HUMAN	Disease (BChE deficiency)	121918556	A	E	497	V
41	UniProt	VAR_040041	R	543	C	CHLE_HUMAN	Disease (BChE deficiency)	199660374	A	R	515	C
42	UniProt	VAR_040042	Q	546	L	CHLE_HUMAN	Disease (BChE deficiency)	---	A	Q	518	L

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (42, 42)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_072094	K	40	R	CHLE_HUMAN	Polymorphism	116047990	A	K	12	R
02	UniProt	VAR_040012	T	52	M	CHLE_HUMAN	Disease (BChE deficiency)	56309853	A	T	24	M
03	UniProt	VAR_040013	F	56	I	CHLE_HUMAN	Disease (BChE deficiency)	531738678	A	F	28	I
04	UniProt	VAR_040014	Y	61	C	CHLE_HUMAN	Disease (BChE deficiency)	116097205	A	Y	33	C
05	UniProt	VAR_072730	A	62	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	34	V
06	UniProt	VAR_040015	P	65	S	CHLE_HUMAN	Disease (BChE deficiency)	148170012	A	P	37	S
07	UniProt	VAR_002360	D	98	G	CHLE_HUMAN	Disease (BChE deficiency)	1799807	A	D	70	G
08	UniProt	VAR_040016	D	98	H	CHLE_HUMAN	Disease (BChE deficiency)	---	A	D	70	H
09	UniProt	VAR_072095	G	103	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A	G	75	R
10	UniProt	VAR_072096	E	118	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A	E	90	D
11	UniProt	VAR_040017	N	124	Y	CHLE_HUMAN	Disease (BChE deficiency)	---	A	N	96	Y
12	UniProt	VAR_072097	I	127	M	CHLE_HUMAN	Polymorphism	755600722	A	I	99	M
13	UniProt	VAR_040018	P	128	S	CHLE_HUMAN	Disease (BChE deficiency)	3732880	A	P	100	S
14	UniProt	VAR_040019	G	143	D	CHLE_HUMAN	Disease (BChE deficiency)	201820739	A	G	115	D
15	UniProt	VAR_040020	L	153	F	CHLE_HUMAN	Disease (BChE deficiency)	747598704	A	L	125	F
16	UniProt	VAR_040021	Y	156	C	CHLE_HUMAN	Disease (BChE deficiency)	121918558	A	Y	128	C
17	UniProt	VAR_040022	V	170	M	CHLE_HUMAN	Disease (BChE deficiency)	527843566	A	V	142	M
18	UniProt	VAR_040023	D	198	E	CHLE_HUMAN	Disease (BChE deficiency)	781368801	A	D	170	E
19	UniProt	VAR_040024	S	226	G	CHLE_HUMAN	Disease (BChE deficiency)	370077923	A	S	198	G
20	UniProt	VAR_040025	A	227	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	199	V
21	UniProt	VAR_040026	A	229	T	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	201	T
22	UniProt	VAR_072098	V	232	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A	V	204	D
23	UniProt	VAR_040027	T	271	M	CHLE_HUMAN	Disease (BChE deficiency)	28933389	A	T	243	M
24	UniProt	VAR_040028	T	278	P	CHLE_HUMAN	Disease (BChE deficiency)	---	A	T	250	P
25	UniProt	VAR_040029	E	283	D	CHLE_HUMAN	Polymorphism	16849700	A	E	255	D
26	UniProt	VAR_040030	K	295	R	CHLE_HUMAN	Disease (BChE deficiency)	115624085	A	K	267	R
27	UniProt	VAR_072099	V	322	M	CHLE_HUMAN	Polymorphism	754644618	A	V	294	M
28	UniProt	VAR_040031	L	335	P	CHLE_HUMAN	Disease (BChE deficiency)	104893684	A	L	307	P
29	UniProt	VAR_040032	A	356	D	CHLE_HUMAN	Disease (BChE deficiency)	770337031	A	A	328	D
30	UniProt	VAR_002362	L	358	I	CHLE_HUMAN	Disease (BChE deficiency)	121918557	A	L	330	I
31	UniProt	VAR_072100	G	361	C	CHLE_HUMAN	Disease (BChE deficiency)	---	A	G	333	C
32	UniProt	VAR_040033	G	393	R	CHLE_HUMAN	Disease (BChE deficiency)	115129687	A	G	365	R
33	UniProt	VAR_040034	R	414	C	CHLE_HUMAN	Disease (BChE deficiency)	745364489	A	R	386	C
34	UniProt	VAR_040035	G	418	V	CHLE_HUMAN	Disease (BChE deficiency)	28933390	A	G	390	V
35	UniProt	VAR_040036	F	446	S	CHLE_HUMAN	Disease (BChE deficiency)	---	A	F	418	S
36	UniProt	VAR_040037	E	488	K	CHLE_HUMAN	Disease (BChE deficiency)	200998515	A	E	460	K
37	UniProt	VAR_072101	R	498	W	CHLE_HUMAN	Polymorphism	115017300	A	R	470	W
38	UniProt	VAR_040038	W	499	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A	W	471	R
39	UniProt	VAR_040039	F	502	L	CHLE_HUMAN	Disease (BChE deficiency)	769316835	A	F	474	L
40	UniProt	VAR_040040	E	525	V	CHLE_HUMAN	Disease (BChE deficiency)	121918556	A	E	497	V
41	UniProt	VAR_040041	R	543	C	CHLE_HUMAN	Disease (BChE deficiency)	199660374	A	R	515	C
42	UniProt	VAR_040042	Q	546	L	CHLE_HUMAN	Disease (BChE deficiency)	---	A	Q	518	L

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (42, 84)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_072094	K	40	R	CHLE_HUMAN	Polymorphism	116047990	A	K	12	R
02	UniProt	VAR_040012	T	52	M	CHLE_HUMAN	Disease (BChE deficiency)	56309853	A	T	24	M
03	UniProt	VAR_040013	F	56	I	CHLE_HUMAN	Disease (BChE deficiency)	531738678	A	F	28	I
04	UniProt	VAR_040014	Y	61	C	CHLE_HUMAN	Disease (BChE deficiency)	116097205	A	Y	33	C
05	UniProt	VAR_072730	A	62	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	34	V
06	UniProt	VAR_040015	P	65	S	CHLE_HUMAN	Disease (BChE deficiency)	148170012	A	P	37	S
07	UniProt	VAR_002360	D	98	G	CHLE_HUMAN	Disease (BChE deficiency)	1799807	A	D	70	G
08	UniProt	VAR_040016	D	98	H	CHLE_HUMAN	Disease (BChE deficiency)	---	A	D	70	H
09	UniProt	VAR_072095	G	103	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A	G	75	R
10	UniProt	VAR_072096	E	118	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A	E	90	D
11	UniProt	VAR_040017	N	124	Y	CHLE_HUMAN	Disease (BChE deficiency)	---	A	N	96	Y
12	UniProt	VAR_072097	I	127	M	CHLE_HUMAN	Polymorphism	755600722	A	I	99	M
13	UniProt	VAR_040018	P	128	S	CHLE_HUMAN	Disease (BChE deficiency)	3732880	A	P	100	S
14	UniProt	VAR_040019	G	143	D	CHLE_HUMAN	Disease (BChE deficiency)	201820739	A	G	115	D
15	UniProt	VAR_040020	L	153	F	CHLE_HUMAN	Disease (BChE deficiency)	747598704	A	L	125	F
16	UniProt	VAR_040021	Y	156	C	CHLE_HUMAN	Disease (BChE deficiency)	121918558	A	Y	128	C
17	UniProt	VAR_040022	V	170	M	CHLE_HUMAN	Disease (BChE deficiency)	527843566	A	V	142	M
18	UniProt	VAR_040023	D	198	E	CHLE_HUMAN	Disease (BChE deficiency)	781368801	A	D	170	E
19	UniProt	VAR_040024	S	226	G	CHLE_HUMAN	Disease (BChE deficiency)	370077923	A	S	198	G
20	UniProt	VAR_040025	A	227	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	199	V
21	UniProt	VAR_040026	A	229	T	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	201	T
22	UniProt	VAR_072098	V	232	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A	V	204	D
23	UniProt	VAR_040027	T	271	M	CHLE_HUMAN	Disease (BChE deficiency)	28933389	A	T	243	M
24	UniProt	VAR_040028	T	278	P	CHLE_HUMAN	Disease (BChE deficiency)	---	A	T	250	P
25	UniProt	VAR_040029	E	283	D	CHLE_HUMAN	Polymorphism	16849700	A	E	255	D
26	UniProt	VAR_040030	K	295	R	CHLE_HUMAN	Disease (BChE deficiency)	115624085	A	K	267	R
27	UniProt	VAR_072099	V	322	M	CHLE_HUMAN	Polymorphism	754644618	A	V	294	M
28	UniProt	VAR_040031	L	335	P	CHLE_HUMAN	Disease (BChE deficiency)	104893684	A	L	307	P
29	UniProt	VAR_040032	A	356	D	CHLE_HUMAN	Disease (BChE deficiency)	770337031	A	A	328	D
30	UniProt	VAR_002362	L	358	I	CHLE_HUMAN	Disease (BChE deficiency)	121918557	A	L	330	I
31	UniProt	VAR_072100	G	361	C	CHLE_HUMAN	Disease (BChE deficiency)	---	A	G	333	C
32	UniProt	VAR_040033	G	393	R	CHLE_HUMAN	Disease (BChE deficiency)	115129687	A	G	365	R
33	UniProt	VAR_040034	R	414	C	CHLE_HUMAN	Disease (BChE deficiency)	745364489	A	R	386	C
34	UniProt	VAR_040035	G	418	V	CHLE_HUMAN	Disease (BChE deficiency)	28933390	A	G	390	V
35	UniProt	VAR_040036	F	446	S	CHLE_HUMAN	Disease (BChE deficiency)	---	A	F	418	S
36	UniProt	VAR_040037	E	488	K	CHLE_HUMAN	Disease (BChE deficiency)	200998515	A	E	460	K
37	UniProt	VAR_072101	R	498	W	CHLE_HUMAN	Polymorphism	115017300	A	R	470	W
38	UniProt	VAR_040038	W	499	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A	W	471	R
39	UniProt	VAR_040039	F	502	L	CHLE_HUMAN	Disease (BChE deficiency)	769316835	A	F	474	L
40	UniProt	VAR_040040	E	525	V	CHLE_HUMAN	Disease (BChE deficiency)	121918556	A	E	497	V
41	UniProt	VAR_040041	R	543	C	CHLE_HUMAN	Disease (BChE deficiency)	199660374	A	R	515	C
42	UniProt	VAR_040042	Q	546	L	CHLE_HUMAN	Disease (BChE deficiency)	---	A	Q	518	L

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 3 (42, 84)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_072094	K	40	R	CHLE_HUMAN	Polymorphism	116047990	A	K	12	R
02	UniProt	VAR_040012	T	52	M	CHLE_HUMAN	Disease (BChE deficiency)	56309853	A	T	24	M
03	UniProt	VAR_040013	F	56	I	CHLE_HUMAN	Disease (BChE deficiency)	531738678	A	F	28	I
04	UniProt	VAR_040014	Y	61	C	CHLE_HUMAN	Disease (BChE deficiency)	116097205	A	Y	33	C
05	UniProt	VAR_072730	A	62	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	34	V
06	UniProt	VAR_040015	P	65	S	CHLE_HUMAN	Disease (BChE deficiency)	148170012	A	P	37	S
07	UniProt	VAR_002360	D	98	G	CHLE_HUMAN	Disease (BChE deficiency)	1799807	A	D	70	G
08	UniProt	VAR_040016	D	98	H	CHLE_HUMAN	Disease (BChE deficiency)	---	A	D	70	H
09	UniProt	VAR_072095	G	103	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A	G	75	R
10	UniProt	VAR_072096	E	118	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A	E	90	D
11	UniProt	VAR_040017	N	124	Y	CHLE_HUMAN	Disease (BChE deficiency)	---	A	N	96	Y
12	UniProt	VAR_072097	I	127	M	CHLE_HUMAN	Polymorphism	755600722	A	I	99	M
13	UniProt	VAR_040018	P	128	S	CHLE_HUMAN	Disease (BChE deficiency)	3732880	A	P	100	S
14	UniProt	VAR_040019	G	143	D	CHLE_HUMAN	Disease (BChE deficiency)	201820739	A	G	115	D
15	UniProt	VAR_040020	L	153	F	CHLE_HUMAN	Disease (BChE deficiency)	747598704	A	L	125	F
16	UniProt	VAR_040021	Y	156	C	CHLE_HUMAN	Disease (BChE deficiency)	121918558	A	Y	128	C
17	UniProt	VAR_040022	V	170	M	CHLE_HUMAN	Disease (BChE deficiency)	527843566	A	V	142	M
18	UniProt	VAR_040023	D	198	E	CHLE_HUMAN	Disease (BChE deficiency)	781368801	A	D	170	E
19	UniProt	VAR_040024	S	226	G	CHLE_HUMAN	Disease (BChE deficiency)	370077923	A	S	198	G
20	UniProt	VAR_040025	A	227	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	199	V
21	UniProt	VAR_040026	A	229	T	CHLE_HUMAN	Disease (BChE deficiency)	---	A	A	201	T
22	UniProt	VAR_072098	V	232	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A	V	204	D
23	UniProt	VAR_040027	T	271	M	CHLE_HUMAN	Disease (BChE deficiency)	28933389	A	T	243	M
24	UniProt	VAR_040028	T	278	P	CHLE_HUMAN	Disease (BChE deficiency)	---	A	T	250	P
25	UniProt	VAR_040029	E	283	D	CHLE_HUMAN	Polymorphism	16849700	A	E	255	D
26	UniProt	VAR_040030	K	295	R	CHLE_HUMAN	Disease (BChE deficiency)	115624085	A	K	267	R
27	UniProt	VAR_072099	V	322	M	CHLE_HUMAN	Polymorphism	754644618	A	V	294	M
28	UniProt	VAR_040031	L	335	P	CHLE_HUMAN	Disease (BChE deficiency)	104893684	A	L	307	P
29	UniProt	VAR_040032	A	356	D	CHLE_HUMAN	Disease (BChE deficiency)	770337031	A	A	328	D
30	UniProt	VAR_002362	L	358	I	CHLE_HUMAN	Disease (BChE deficiency)	121918557	A	L	330	I
31	UniProt	VAR_072100	G	361	C	CHLE_HUMAN	Disease (BChE deficiency)	---	A	G	333	C
32	UniProt	VAR_040033	G	393	R	CHLE_HUMAN	Disease (BChE deficiency)	115129687	A	G	365	R
33	UniProt	VAR_040034	R	414	C	CHLE_HUMAN	Disease (BChE deficiency)	745364489	A	R	386	C
34	UniProt	VAR_040035	G	418	V	CHLE_HUMAN	Disease (BChE deficiency)	28933390	A	G	390	V
35	UniProt	VAR_040036	F	446	S	CHLE_HUMAN	Disease (BChE deficiency)	---	A	F	418	S
36	UniProt	VAR_040037	E	488	K	CHLE_HUMAN	Disease (BChE deficiency)	200998515	A	E	460	K
37	UniProt	VAR_072101	R	498	W	CHLE_HUMAN	Polymorphism	115017300	A	R	470	W
38	UniProt	VAR_040038	W	499	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A	W	471	R
39	UniProt	VAR_040039	F	502	L	CHLE_HUMAN	Disease (BChE deficiency)	769316835	A	F	474	L
40	UniProt	VAR_040040	E	525	V	CHLE_HUMAN	Disease (BChE deficiency)	121918556	A	E	497	V
41	UniProt	VAR_040041	R	543	C	CHLE_HUMAN	Disease (BChE deficiency)	199660374	A	R	515	C
42	UniProt	VAR_040042	Q	546	L	CHLE_HUMAN	Disease (BChE deficiency)	---	A	Q	518	L

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (2, 2)

Exons (2, 2)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:523
 aligned with CHLE_HUMAN | P06276 from UniProtKB/Swiss-Prot  Length:602

    Alignment length:526
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521       531       541       551      
           CHLE_HUMAN    32 IIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV 557
               SCOP domains d1p0ia_ A: Butyryl cholinesterase                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              SCOP domains
               CATH domains 1p0iA00 A:4-529  [code=3.40.50.1820, no name defined]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          CATH domains
               Pfam domains COesterase-1p0iA01 A:4-522                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ------- Pfam domains
         Sec.struct. author .eeee..eeee.eeeee..eeeeeeeeee.....hhhhh............eee..................hhhhhh............eeeeeee......eeeeeee...........hhhhhhhhhhhhhh.eeeee...hhhhhhh..........hhhhhhhhhhhhhhhhhhhhh.eeeeeeeeeeehhhhhhhhhhhhhhhhhhhh.eeeee...........hhhhhhhhhhhhhhhh.....hhhhhhhhhh..hhhhhhhhhhhhh.....................hhhhhhhh.......eeeeee...hhhhhh..............hhhhhhhhhhhhh...hhhhhhhhhhhhh...--...hhhhhhhhhhhhhhhhhhhhhhhhhhhhh....eeeeee.........hhhhh.....hhhhhhhhhhh...-.hhhhhhhhhhhhhhhhhhhhhh....................eeeee......eee..hhhhhhhhhh..... Sec.struct. author
             SAPs(SNPs) (1) --------R-----------M---I----CV--S--------------------------------G----R--------------D-----Y--MS--------------D---------F--C-------------M---------------------------E---------------------------GV-T--D--------------------------------------M------P----D-----------R--------------------------M------------P--------------------D-I--C-------------------------------R--------------------C---V---------------------------S-----------------------------------------K---------WR--L----------------------V-----------------C--L----------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------H--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE --------------------------------------------------------------------------------------CARBOXYLEST------------------------------------------------------------------------------------CARBOXYLESTERASE----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: A:4-478 (gaps) UniProt: 1-506 [INCOMPLETE]                                                                                                                                                                                                                                                                                                                                                                                                                                  --------------------------------------------------- Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.4  PDB: A:478-529 UniProt: 506-562            Transcript 1 (2)
                 1p0i A   4 IIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWV--QRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRD-YTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV 529
                                    13        23        33        43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373   |  |383       393       403       413       423       433       443       453| |    463       473       483       493       503       513       523      
                                                                                                                                                                                                                                                                                                                                                                                                               377  |                                                                       454 |                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                  380                                                                         456

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 1)

CATH Domains (1, 1)

Pfam Domains (1, 1)

Gene Ontology (28, 28)

Asymmetric Unit(hide GO term definitions)

Chain A (CHLE_HUMAN | P06276)

molecular function
	GO:0003990	acetylcholinesterase activity	Catalysis of the reaction: acetylcholine + H2O = choline + acetate.
	GO:0001540	amyloid-beta binding	Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
	GO:0052689	carboxylic ester hydrolase activity	Catalysis of the hydrolysis of a carboxylic ester bond.
	GO:0003824	catalytic activity	Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
	GO:0033265	choline binding	Interacting selectively and non-covalently with choline, the amine 2-hydroxy-N,N,N-trimethylethanaminium.
	GO:0004104	cholinesterase activity	Catalysis of the reaction: an acylcholine + H2O = choline + a carboxylic acid anion.
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0016788	hydrolase activity, acting on ester bonds	Catalysis of the hydrolysis of any ester bond.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
biological process
	GO:0019695	choline metabolic process	The chemical reactions and pathways involving choline (2-hydroxyethyltrimethylammonium), an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids and in the neurotransmitter acetylcholine.
	GO:0050783	cocaine metabolic process	The chemical reactions and pathways involving cocaine, an alkaloid obtained from the dried leaves of the shrub Erythroxylon coca. It is a cerebral stimulant and narcotic.
	GO:0007612	learning	Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience.
	GO:0008285	negative regulation of cell proliferation	Any process that stops, prevents or reduces the rate or extent of cell proliferation.
	GO:0050805	negative regulation of synaptic transmission	Any process that stops, prevents, or reduces the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
	GO:0014016	neuroblast differentiation	The process in which a relatively unspecialized cell acquires specialized features of a neuroblast. There are at least four stages through which the pluripotent cells of epiblast or blastula become neuroblasts.
	GO:0043279	response to alkaloid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active.
	GO:0042493	response to drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0051593	response to folic acid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus.
	GO:0051384	response to glucocorticoid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0005783	endoplasmic reticulum	The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
	GO:0005788	endoplasmic reticulum lumen	The volume enclosed by the membranes of the endoplasmic reticulum.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005641	nuclear envelope lumen	The region between the two lipid bilayers of the nuclear envelope; 20-40 nm wide.

Visualization

Interactive Views

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		BUA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		CL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FUC	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GOL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MES	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		SO4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]
		BC6	[ RasMol ]	+environment [ RasMol ]
		BC7	[ RasMol ]	+environment [ RasMol ]
		BC8	[ RasMol ]	+environment [ RasMol ]
		BC9	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Ala A:101 - Pro A:102	[ RasMol ]

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]
		Biological Unit 3	[ Jena3D ]

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (7, 18)

Sites (18, 18)

SS Bonds (3, 3)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (42, 42)

PROSITE Motifs (2, 2)

Exons (2, 2)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 1)

CATH Domains (1, 1)

Pfam Domains (1, 1)

Gene Ontology (28, 28)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File